Tyrosine-protein kinase ABL Inhibitor
     
Home > PRODUCTS > Biochemicals > Various Inhibitors

Newsletter Subscription

Stay updated with our new products and services. You can unsubscribe at any time.


Tyrosine-protein kinase ABL Inhibitor

N-[5-(4-chlorobenzyl)-1,3-thiazol-2-yl]-2-thiophenecarboxamide

Potent ABL inhibitor, with Ki values of 0.624±0.012 µM.

nw-abl_inhibitor

OTAVAchemicals Catalogue Number:   0117391283

CAS Registry Number: N/A

Purity: 98%

 

Ref.: F. Manetti et al. N-(thiazol-2-yl)-2-thiophene carboxamide derivatives as Abl inhibitors identified by a pharmacophore-based database screening of commercially available compounds.  Bioorg. Med. Chem. Lett. 18 (2008) 4328–4331.

Abstract: Suggestions derived from a previous ligand-based ligand design approach and docking calculations aimed at finding compound with affinity toward Abl and molecular scaffolds previously untested as Abl inhibitors, led to the identification of commercially available N-(thiazol-2-yl)-2-thiophene carboxamide derivatives with affinity in a cell-free assay up to low nanomolar concentrations, significantly enhanced with respect to that of their parent compounds previously reported. In particular, among compounds of the Asinex database, molecular docking simulations guided the choice of high-affinity ligands, predicting their binding mode and their interaction pattern with the Abl catalytic binding site. Moreover, affinity of the new compounds was also rationalized in terms of their interactions with the enzyme.

 
SSL